Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04399694 · ClinicalTrials.gov registry record
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 56
- Enrollment target
NCT04399694: Completed study, sponsored by Duke University.
NCT04399694 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04399694 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The goal of this study is to identify and characterize novel non-coding and splicing variants that may contribute to genetic disorders. We will particularly focus on patients with a diagnosed genetic disorder that has inconclusive genetic findings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2020-03-03 |
| Est. Completion | 2024-04-11 |
What the finished NCT04399694 record still lists
NCT04399694 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04399694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04399694 about?
NCT04399694 is a clinical study titled "Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders". The goal of this study is to identify and characterize novel non-coding and splicing variants that may contribute to genetic disorders. We will particularly focus on patients with a diagnosed genetic disorder that has inconclusive genetic findings.
What is the current status of trial NCT04399694?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2020-03-03. Estimated completion is 2024-04-11.
Who is sponsoring clinical trial NCT04399694?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI